Healio Minute Podcast, Neurology Edition: Top Headlines - Week of October 24, 2022

ByJessica Jones

In this edition, headache characteristics to classify as migraine; FDA grants breakthrough device designation; engineering company to develop neuroactive compounds from plants and more.

Read the full coverage here:

Evaluate headache characteristics to classify as migraine

FDA grants breakthrough device designation for brain implant technology

New genetic engineering company aims to develop neuroactive compounds from plants, fungi

Angiotensin receptor blocker therapy associated with decreased incidence of epilepsy

Theranica announces positive results from clinical trial for migraine treatment device

References:

Diamond M. Migraine, chronic migraine and medication overuse headache: Where are we today? Presented at: PAINWeek; Sept. 6-9, 2022; Las Vegas

Doege C, et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.3413.

Press Release.

Press Release

Sources/Disclosures

Collapse

Disclosures: Please see each study for relevant financial disclosures.

Read more

Healio Minute Podcast, Neurology Edition: Top Headlines - Week of October 24, 2022

Healio Minute: Neurology Edition

Related Content